A comprehensive observational study published in Nature Medicine analyzed the health impacts of GLP-1 receptor agonists, identifying 42 potential benefits and 19 potential risks. The research highlights that these drugs affect multiple organ systems beyond their primary use in diabetes and weight loss. While confirming protective effects for the heart and kidneys, the study also flagged rare but serious safety concerns, including gastrointestinal conditions and potential neurological risks.
The most-used peptide combinations, what the research actually says, and where to buy — one page, one email.
No spam. Unsubscribe anytime.